Summary & Overview
CPT 44100: Small Intestine Biopsy via Oral Capsule
CPT code 44100 designates a minimally invasive diagnostic procedure in which a capsule is introduced orally to obtain biopsy samples from the small intestine. The code represents a targeted approach to small-bowel tissue sampling that can aid diagnosis of inflammatory, infectious, and neoplastic conditions when traditional endoscopy is limited. Nationally, accurate coding of this service matters for procedural reporting, clinical registries, and alignment of facility and professional claims.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for capsule-based small-bowel biopsy, common sites of service for billing, typical service descriptors, and the set of common claim modifiers used with the code. The publication also summarizes benchmark usage patterns where available, highlights relevant policy and billing considerations affecting coverage and payment, and outlines implications for coding compliance and documentation.
This national summary is intended for revenue cycle leaders, coding professionals, gastroenterology clinicians, and payers seeking clarity on procedural identification, reporting practices, and the operational setting for CPT code 44100. Data not available in the input.
Billing Code Overview
CPT code 44100 describes a small intestine biopsy performed via an ingestible capsule introduced through the mouth. The procedure involves placement of a diagnostic capsule to obtain tissue samples from the small bowel for histologic evaluation.
Service Type: Endoscopic capsule biopsy / diagnostic capsule procedure
Typical Site of Service: Hospital outpatient department or ambulatory surgical center; procedure initiated via the oral route and performed under clinical monitoring
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 45–70-year-old adult with unexplained chronic iron-deficiency anemia, intermittent obscure gastrointestinal bleeding, or malabsorption symptoms after negative upper endoscopy and colonoscopy. The gastroenterologist recommends biopsy of the small intestine using an ingestible biopsy capsule to obtain mucosal tissue samples for histology, celiac disease evaluation, or to identify sources of mid‑gut bleeding. The procedure workflow: pre-procedure evaluation with medical history, medication reconciliation (anticoagulant management), informed consent, and fasting. The patient swallows the biopsy capsule in an outpatient endoscopy suite or ambulatory surgical center. The capsule transmits location and timing; enzymatic or timed release obtains tissue specimens while traversing the small bowel. After capsule retrieval or natural passage, specimens are submitted to pathology. Post-procedure monitoring is brief; patient education includes signs of capsule retention or obstruction. Typical site of service: outpatient endoscopy suite or ambulatory surgical center. Service type: diagnostic outpatient endoscopic biopsy procedure of the small intestine using an ingestible capsule.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — neutral reporting | When no special modifier applies and services are reported as standard. |